Company intelligence / Profile preview

CSIBRC

Ownership: Private
Development stage: Other

Overview

Champions Oncology offers personalized cancer care and preclinical research services using its proprietary Tumorgraft Technology Platform. This involves implanting human tumors into immune-deficient mice to create patient-derived xenografts for drug testing and biomarker discovery[9].

Therapeutic areas: Oncology
Modalities: Tumorgraft (Patient-Derived Xenograft) modelsPersonalized oncology services (not a therapeutic developer)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on CSIBRC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSIBRC.

Explore the full profile